Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
Fabrizio Martora, Massimiliano Scalvenzi, Teresa Battista, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 2525-2536
Open Access | Times Cited: 16

Showing 16 citing articles:

Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
Fabrizio Martora, Claudio Marasca, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 159-166
Open Access | Times Cited: 23
JAK Inhibitors in Psoriatic Disease
Matteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3129-3145
Open Access | Times Cited: 16
Hypergammaglobulinemia in Hidradenitis Suppurativa Patients: A New Emerging Association
Fabrizio Martora, Teresa Battista, Antonella Giordano, et al.
Clinical Cosmetic and Investigational Dermatology (2025) Vol. Volume 18, pp. 1-5
Open Access
Severe Paradoxical Scalp Psoriasis Induced by Bimekizumab in a Young Multifailure Hidradenitis Suppurativa Patient
Fabrizio Martora, Teresa Battista, Luca Potestio, et al.
Dermatology and Therapy (2025)
Open Access
Plant-Based Foods for Chronic Skin Diseases: A Focus on the Mediterranean Diet
Giuseppe Annunziata, Ludovica Verde, Alexander Zink, et al.
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Open Access
Hidradenitis Suppurativa Cancer Risk: A Review of the Literature
Fabrizio Martora, Nello Tommasino, Teresa Battista, et al.
Clinical Cosmetic and Investigational Dermatology (2025) Vol. Volume 18, pp. 617-626
Open Access
The preclinical discovery and development of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa
Klaudia Knecht-Gurwin, Łukasz Matusiak, Jacek C. Szepietowski
Expert Opinion on Drug Discovery (2025)
Closed Access
The role of interleukin inhibitors in the treatment of hidradenitis suppurativa; a systematic review of clinical trials
Nazila Heidari, Amirhossein Heidari, Sara Eghbali, et al.
Autoimmunity Reviews (2025), pp. 103818-103818
Closed Access
A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
Nazila Heidari, Rad Ghannadzadeh Kermani Pour, Melina Farshbafnadi, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Anti‐IL17 Secukinumab in hidradenitis suppurativa: A long‐term drug survival analysis
Gabriele Roccuzzo, Federica Repetto, Silvia Giordano, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 7
Closed Access | Times Cited: 2
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study
Luigi Gargiulo, Luciano Ibba, Alessandra Narcisi, et al.
Dermatology Practical & Conceptual (2024) Vol. 14, Iss. 4, pp. e2024250-e2024250
Open Access | Times Cited: 2
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report
Fabrizio Martora, Teresa Battista, Luca Potestio, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 483-487
Open Access | Times Cited: 1
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report
Fabrizio Martora, Maria Carmela Annunziata, Luca Potestio, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 1275-1279
Open Access | Times Cited: 1
Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature
Fabrizio Martora, Nello Tommasino, Claudio Brescia, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1465-1465
Open Access | Times Cited: 1
Effect of adalimumab treatment on inflammatory and hematological parameters in patients with Hidradenitis suppurativa
Kadir Kaya, Özlem Devran Gevher
Cutaneous and Ocular Toxicology (2024), pp. 1-5
Closed Access
Scarring Hidradenitis Suppurativa with Phrynoderma-like Eruption, Alopecia and Elevated IL-18
Frank Z. Jing, Mika Yamanaka‐Takaichi, Takashi Satoh, et al.
JAAD Case Reports (2024) Vol. 55, pp. 116-120
Open Access
Page 1

Scroll to top